184 related articles for article (PubMed ID: 37265546)
1. Cholesterol twists the transmembrane Di-Gly region of amyloid-precursor protein.
Wang DT; Tang TYC; Kuo CT; Yu YT; Chen EHL; Lee MT; Tsai RF; Chen HY; Chiang YW; Chen RPY
PNAS Nexus; 2023 May; 2(5):pgad162. PubMed ID: 37265546
[TBL] [Abstract][Full Text] [Related]
2. Analysis of Non-Amyloidogenic Mutations in APP Supports Loss of Function Hypothesis of Alzheimer's Disease.
Kim M; Bezprozvanny I
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768421
[TBL] [Abstract][Full Text] [Related]
3. Familial Alzheimer's disease mutations in amyloid protein precursor alter proteolysis by γ-secretase to increase amyloid β-peptides of ≥45 residues.
Devkota S; Williams TD; Wolfe MS
J Biol Chem; 2021; 296():100281. PubMed ID: 33450230
[TBL] [Abstract][Full Text] [Related]
4. Zinc and Copper Differentially Modulate Amyloid Precursor Protein Processing by γ-Secretase and Amyloid-β Peptide Production.
Gerber H; Wu F; Dimitrov M; Garcia Osuna GM; Fraering PC
J Biol Chem; 2017 Mar; 292(9):3751-3767. PubMed ID: 28096459
[TBL] [Abstract][Full Text] [Related]
5. γ-Secretase structure and activity are modified by alterations in its membrane localization and ambient environment.
Suzuki T; Sobu Y; Hata S
J Biochem; 2022 Mar; 171(3):253-256. PubMed ID: 34865063
[TBL] [Abstract][Full Text] [Related]
6. Specific Mutations in the Cholesterol-Binding Site of APP Alter Its Processing and Favor the Production of Shorter, Less Toxic Aβ Peptides.
Hanbouch L; Schaack B; Kasri A; Fontaine G; Gkanatsiou E; Brinkmalm G; Camporesi E; Portelius E; Blennow K; Mourier G; Gilles N; Millan MJ; Marquer C; Zetterberg H; Boussicault L; Potier MC
Mol Neurobiol; 2022 Nov; 59(11):7056-7073. PubMed ID: 36076005
[TBL] [Abstract][Full Text] [Related]
7. BACE1: the beta-secretase enzyme in Alzheimer's disease.
Vassar R
J Mol Neurosci; 2004; 23(1-2):105-14. PubMed ID: 15126696
[TBL] [Abstract][Full Text] [Related]
8. The beta-secretase, BACE: a prime drug target for Alzheimer's disease.
Vassar R
J Mol Neurosci; 2001 Oct; 17(2):157-70. PubMed ID: 11816789
[TBL] [Abstract][Full Text] [Related]
9. [Alzheimer disease: cellular and molecular aspects].
Octave JN
Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248
[TBL] [Abstract][Full Text] [Related]
10. Changed membrane integration and catalytic site conformation are two mechanisms behind the increased Aβ42/Aβ40 ratio by presenilin 1 familial Alzheimer-linked mutations.
Wanngren J; Lara P; Ojemalm K; Maioli S; Moradi N; Chen L; Tjernberg LO; Lundkvist J; Nilsson I; Karlström H
FEBS Open Bio; 2014; 4():393-406. PubMed ID: 24918054
[TBL] [Abstract][Full Text] [Related]
11. Dissociation between the processivity and total activity of γ-secretase: implications for the mechanism of Alzheimer's disease-causing presenilin mutations.
Quintero-Monzon O; Martin MM; Fernandez MA; Cappello CA; Krzysiak AJ; Osenkowski P; Wolfe MS
Biochemistry; 2011 Oct; 50(42):9023-35. PubMed ID: 21919498
[TBL] [Abstract][Full Text] [Related]
12. Alzheimer presenilin-1 mutations dramatically reduce trimming of long amyloid β-peptides (Aβ) by γ-secretase to increase 42-to-40-residue Aβ.
Fernandez MA; Klutkowski JA; Freret T; Wolfe MS
J Biol Chem; 2014 Nov; 289(45):31043-52. PubMed ID: 25239621
[TBL] [Abstract][Full Text] [Related]
13. Bexarotene Binds to the Amyloid Precursor Protein Transmembrane Domain, Alters Its α-Helical Conformation, and Inhibits γ-Secretase Nonselectively in Liposomes.
Kamp F; Scheidt HA; Winkler E; Basset G; Heinel H; Hutchison JM; LaPointe LM; Sanders CR; Steiner H; Huster D
ACS Chem Neurosci; 2018 Jul; 9(7):1702-1713. PubMed ID: 29717863
[TBL] [Abstract][Full Text] [Related]
14. Designed Helical Peptides as Functional Probes for γ-Secretase.
Philip AT; Devkota S; Malvankar S; Bhattarai S; Meneely KM; Williams TD; Wolfe MS
Biochemistry; 2019 Nov; 58(44):4398-4407. PubMed ID: 31625391
[TBL] [Abstract][Full Text] [Related]
15. Amyloid-beta protein clearance and degradation (ABCD) pathways and their role in Alzheimer's disease.
Baranello RJ; Bharani KL; Padmaraju V; Chopra N; Lahiri DK; Greig NH; Pappolla MA; Sambamurti K
Curr Alzheimer Res; 2015; 12(1):32-46. PubMed ID: 25523424
[TBL] [Abstract][Full Text] [Related]
16. Major carboxyl terminal fragments generated by γ-secretase processing of the Alzheimer amyloid precursor are 50 and 51 amino acids long.
Pinnix I; Ghiso JA; Pappolla MA; Sambamurti K
Am J Geriatr Psychiatry; 2013 May; 21(5):474-83. PubMed ID: 23570890
[TBL] [Abstract][Full Text] [Related]
17. Impact of amyloid precursor protein hydrophilic transmembrane residues on amyloid-beta generation.
Oestereich F; Bittner HJ; Weise C; Grohmann L; Janke LK; Hildebrand PW; Multhaup G; Munter LM
Biochemistry; 2015 May; 54(17):2777-84. PubMed ID: 25875527
[TBL] [Abstract][Full Text] [Related]
18. Amyloid beta 42 peptide (Abeta42)-lowering compounds directly bind to Abeta and interfere with amyloid precursor protein (APP) transmembrane dimerization.
Richter L; Munter LM; Ness J; Hildebrand PW; Dasari M; Unterreitmeier S; Bulic B; Beyermann M; Gust R; Reif B; Weggen S; Langosch D; Multhaup G
Proc Natl Acad Sci U S A; 2010 Aug; 107(33):14597-602. PubMed ID: 20679249
[TBL] [Abstract][Full Text] [Related]
19. Transmembrane Substrate Determinants for γ-Secretase Processing of APP CTFβ.
Fernandez MA; Biette KM; Dolios G; Seth D; Wang R; Wolfe MS
Biochemistry; 2016 Oct; 55(40):5675-5688. PubMed ID: 27649271
[TBL] [Abstract][Full Text] [Related]
20. Dimerization of the transmembrane domain of amyloid precursor proteins and familial Alzheimer's disease mutants.
Gorman PM; Kim S; Guo M; Melnyk RA; McLaurin J; Fraser PE; Bowie JU; Chakrabartty A
BMC Neurosci; 2008 Jan; 9():17. PubMed ID: 18234110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
